menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

ATHENA Trial: Reducing Cardiovascular Deaths By Preventing Recurrent Atrial Fibrillation

close
ATHENA Trial: Reducing Cardiovascular Deaths By Preventing Recurrent Atrial Fibrillation
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Can we reduce cardiovascular deaths by preventing a recurrence of atrial fibrillation?  Dr. Eric Prystowsky, Director of Electrophysiology at St. Vincent Hospital in Indianapolis, Indiana, will discuss the results of the ATHENA trial; a study using dronedarone, an amiodarone-like medication, that was shown to significantly reduce cardiovascular deaths and hospitalizations due to atrial fibrillation and acute coronary syndromes. Join host Dr. Matthew Sorrentino.

     

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Can we reduce cardiovascular deaths by preventing a recurrence of atrial fibrillation?  Dr. Eric Prystowsky, Director of Electrophysiology at St. Vincent Hospital in Indianapolis, Indiana, will discuss the results of the ATHENA trial; a study using dronedarone, an amiodarone-like medication, that was shown to significantly reduce cardiovascular deaths and hospitalizations due to atrial fibrillation and acute coronary syndromes. Join host Dr. Matthew Sorrentino.

     

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 5/28/20